Cargando…
Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas
A central aim in cancer research is to identify genes with altered expression patterns in tumor specimens and their potential role in tumorigenesis. Most types of tumors, including hepatocellular carcinoma (HCC), are heterogeneous in terms of genotype and phenotype. Thus, traditional analytical meth...
Autores principales: | Teng, Fei, Guo, Meng, Liu, Fang, Wang, Ce, Dong, Jiayong, Zhang, Lei, Zou, You, Chen, Rui, Sun, Keyan, Fu, Hong, Fu, Zhiren, Guo, Wenyuan, Ding, Guoshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288206/ https://www.ncbi.nlm.nih.gov/pubmed/27447551 http://dx.doi.org/10.18632/oncotarget.10670 |
Ejemplares similares
-
Hepatoprotective Action of Radix Paeoniae Rubra Aqueous Extract against CCl(4)-Induced Hepatic Damage
por: Li, Ruidong, et al.
Publicado: (2011) -
A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective
por: Bao, Haili, et al.
Publicado: (2022) -
MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1
por: Zhan, Yangyang, et al.
Publicado: (2017) -
A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma
por: Luo, Yi, et al.
Publicado: (2022) -
The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders
por: Yong, Cai, et al.
Publicado: (2014)